{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T02:07:37Z","timestamp":1793412457718,"version":"4.5.0"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,4]]},"abstract":"<jats:p>A 7-year-old girl with tuberculous (TB) meningitis developed optochiasmatic arachnoiditis, a vision-threatening paradoxical reaction, after starting TB treatment including adjunctive steroid therapy. She was treated with infliximab with complete recovery. This is the first report of the use of a tissue necrosis factor \u03b1 inhibitor for the treatment of a severe paradoxical TB reaction in a child.<\/jats:p>","DOI":"10.1097\/inf.0000000000002578","type":"journal-article","created":{"date-parts":[[2020,1,15]],"date-time":"2020-01-15T07:03:53Z","timestamp":1579071833000},"page":"e42-e45","source":"Crossref","is-referenced-by-count":19,"title":["Successful Treatment of a Severe Vision-Threatening Paradoxical Tuberculous Reaction with Infliximab"],"prefix":"10.1097","volume":"39","author":[{"given":"Yara-Natalie","family":"Abo","sequence":"first","affiliation":[{"name":"Infectious Diseases Unit, The Royal Children\u2019s Hospital Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel","family":"Curtis","sequence":"additional","affiliation":[{"name":"Infectious Diseases Unit, The Royal Children\u2019s Hospital Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Coen","family":"Butters","sequence":"additional","affiliation":[{"name":"Infectious Diseases Unit, The Royal Children\u2019s Hospital Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas H.","family":"Rozen","sequence":"additional","affiliation":[{"name":"Infectious Diseases Unit, The Royal Children\u2019s Hospital Melbourne, Victoria, Australia"},{"name":"Department of Paediatrics, The University of Melbourne, Victoria, Australia"},{"name":"Infectious Diseases Group, Murdoch Children\u2019s Research Institute, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben J.","family":"Marais","sequence":"additional","affiliation":[{"name":"Infectious Diseases Unit, The Children\u2019s Hospital at Westmead, New South Wales, Australia"},{"name":"University of Sydney, New South Wales, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Gwee","sequence":"additional","affiliation":[{"name":"Infectious Diseases Unit, The Royal Children\u2019s Hospital Melbourne, Victoria, Australia"},{"name":"Department of Paediatrics, The University of Melbourne, Victoria, Australia"},{"name":"Infectious Diseases Group, Murdoch Children\u2019s Research Institute, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230912","first-page":"153","article-title":"Epidemiology and disease burden of tuberculosis in children: a global perspective.","volume":"7","author":"Seddon","year":"2014","journal-title":"Infect Drug Resist"},{"key":"R3-20230912","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1056\/NEJMra1008049","article-title":"Tuberculosis in children.","volume":"367","author":"Perez-Velez","year":"2012","journal-title":"N Engl J Med"},{"key":"R4-20230912","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jinf.2009.06.011","article-title":"British Infection Society guidelines for the diagnosis and treatment of tuberculosis of the central nervous system in adults and children.","volume":"59","author":"Thwaites","year":"2009","journal-title":"J Infect"},{"key":"R5-20230912","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1186\/s12879-016-1625-9","article-title":"Paradoxical reaction in tuberculous meningitis: presentation, predictors and impact on prognosis.","volume":"16","author":"Singh","year":"2016","journal-title":"BMC Infect Dis"},{"key":"R6-20230912","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jns.2009.12.012","article-title":"Vision impairment in tuberculous meningitis: predictors and prognosis.","volume":"290","author":"Sinha","year":"2010","journal-title":"J Neurol Sci"},{"key":"R7-20230912","doi-asserted-by":"crossref","first-page":"732","DOI":"10.4103\/0028-3886.72194","article-title":"Tuberculous optochiasmatic arachnoiditis.","volume":"58","author":"Anupriya","year":"2010","journal-title":"Neurol India"},{"key":"R8-20230912","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1542\/peds.99.2.226","article-title":"Effect of corticosteroids on intracranial pressure, computed tomographic findings, and clinical outcome in young children with tuberculous meningitis.","volume":"99","author":"Schoeman","year":"1997","journal-title":"Pediatrics"},{"key":"R9-20230912","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/nrneurol.2017.120","article-title":"Tuberculous meningitis.","volume":"13","author":"Wilkinson","year":"2017","journal-title":"Nat Rev Neurol"},{"key":"R10-20230912","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1093\/clinids\/21.4.924","article-title":"Concentrations of interferon gamma, tumor necrosis factor alpha, and interleukin-1 beta in the cerebrospinal fluid of children treated for tuberculous meningitis.","volume":"21","author":"Donald","year":"1995","journal-title":"Clin Infect Dis"},{"key":"R11-20230912","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1086\/515327","article-title":"A combination of thalidomide plus antibiotics protects rabbits from mycobacterial meningitis-associated death.","volume":"177","author":"Tsenova","year":"1998","journal-title":"J Infect Dis"},{"key":"R12-20230912","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1177\/088307380001500801","article-title":"Adjunctive thalidomide therapy of childhood tuberculous meningitis: possible anti-inflammatory role.","volume":"15","author":"Schoeman","year":"2000","journal-title":"J Child Neurol"},{"key":"R13-20230912","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1177\/0883073809350507","article-title":"Tuberculous meningitis-related optic neuritis: recovery of vision with thalidomide in 4 consecutive cases.","volume":"25","author":"Schulman","year":"2010","journal-title":"J Child Neurol"},{"key":"R14-20230912","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1177\/088307380401900402","article-title":"Adjunctive thalidomide therapy for childhood tuberculous meningitis: results of a randomized study.","volume":"19","author":"Schoeman","year":"2004","journal-title":"J Child Neurol"},{"key":"R15-20230912","doi-asserted-by":"crossref","first-page":"156","DOI":"10.5694\/mja14.00716","article-title":"Infliximab therapy in two cases of severe neurotuberculosis paradoxical reaction.","volume":"202","author":"Molton","year":"2015","journal-title":"Med J Aust"},{"key":"R16-20230912","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/RHU.0b013e318258b725","article-title":"A life-threatening central nervous system-tuberculosis inflammatory reaction nonresponsive to corticosteroids and successfully controlled by infliximab in a young patient with a variant of juvenile idiopathic arthritis.","volume":"18","author":"Jorge","year":"2012","journal-title":"J Clin Rheumatol"},{"key":"R17-20230912","doi-asserted-by":"crossref","first-page":"e83","DOI":"10.1086\/592695","article-title":"Therapeutic use of infliximab in tuberculosis to control severe paradoxical reaction of the brain and lymph nodes.","volume":"47","author":"Blackmore","year":"2008","journal-title":"Clin Infect Dis"},{"key":"R18-20230912","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1093\/cid\/civ841","article-title":"A paradoxical treatment for a paradoxical condition: infliximab use in three cases of mycobacterial IRIS.","volume":"62","author":"Hsu","year":"2016","journal-title":"Clin Infect Dis"},{"key":"R19-20230912","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1086\/427941","article-title":"Paradoxical response to antituberculous therapy in infliximab-treated patients with disseminated tuberculosis.","volume":"40","author":"Vidal","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"suppl 3","key":"R20-20230912","doi-asserted-by":"crossref","first-page":"e333","DOI":"10.1016\/j.ijid.2010.03.002","article-title":"Prolonged paradoxical response to anti-tuberculous treatment after infliximab.","volume":"14","author":"Melboucy-Belkhir","year":"2010","journal-title":"Int J Infect Dis"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000002578","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T22:34:32Z","timestamp":1694558072000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000002578"}},"subtitle":["First Pediatric Use"],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000002578","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]}}}